📊 UFPT Key Takeaways
Is Ufp Technologies Inc. (UFPT) a Good Investment?
UFP Technologies exhibits strong topline growth (19.5% YoY) and solid profitability margins (11.3% net margin), but negative free cash flow (-$2.5M) and critically low returns on capital (4% ROE, 2.6% ROA) signal inefficient capital deployment. While the conservative balance sheet (0.31x debt/equity) prevents imminent distress, the disconnect between accounting profits and cash generation raises sustainability questions that must be resolved.
Ufp Technologies Inc. Key Strengths (UFPT)
- Strong revenue growth of 19.5% YoY in medical device sector with EPS growth of 15.4%
- Solid profitability with 11.3% net margin and 15.2% operating margin demonstrating operational efficiency
- Conservative capital structure with 0.31x debt/equity ratio and 4.3x interest coverage
- Strong liquidity position with 2.91x current ratio and 1.69x quick ratio
- Adequate gross margin of 28.8% indicating competitive positioning and pricing power
UFPT Stock Risks: Ufp Technologies Inc. Investment Risks
- Negative free cash flow of -$2.5M despite $17.5M net income indicates poor cash conversion and working capital concerns
- Operating cash flow of only $3.2M (2.1% of revenue) is inadequate for sustainable operations and debt servicing
- Critically low ROE (4.0%) and ROA (2.6%) demonstrate inefficient deployment of $438.9M equity and $674.7M assets
- Minimal cash reserves of $20M with negative FCF trends threaten financial flexibility and debt service capability
- Unexplained gap between profitability and cash generation suggests potential inventory bloat, receivables issues, or unsustainable practices
Key Metrics to Watch
- Free cash flow conversion and operating cash flow as percentage of revenue - must achieve positive FCF
- Return on Equity and Return on Assets trajectory - 4% and 2.6% are unacceptably low
- Days inventory outstanding and days sales outstanding - likely drivers of negative FCF
- Cash balance and debt service coverage ratio - sustainability of leverage with negative cash generation
- Capital expenditure intensity and depreciation trends - validate reinvestment requirements
Ufp Technologies Inc. (UFPT) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.91x current ratio provides a solid financial cushion.
UFPT Profit Margin, ROE & Profitability Analysis
UFPT vs Healthcare Sector: How Ufp Technologies Inc. Compares
How Ufp Technologies Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Ufp Technologies Inc. Stock Overvalued? UFPT Valuation Analysis 2026
Based on fundamental analysis, Ufp Technologies Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Ufp Technologies Inc. Balance Sheet: UFPT Debt, Cash & Liquidity
UFPT Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Ufp Technologies Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $1.27 reflects profitable operations.
UFPT Revenue Growth, EPS Growth & YoY Performance
UFPT Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $148.1M | $17.2M | $2.21 |
| Q3 2025 | $145.2M | $12.7M | $2.11 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Ufp Technologies Inc. Dividends, Buybacks & Capital Allocation
UFPT SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Ufp Technologies Inc. (CIK: 0000914156)
📋 Recent SEC Filings
❓ Frequently Asked Questions about UFPT
What is the AI rating for UFPT?
Ufp Technologies Inc. (UFPT) has an AI grade of B with 62% confidence, based on fundamental analysis of SEC EDGAR filings.
What are UFPT's key strengths?
Claude: Strong revenue growth of 19.5% YoY in medical device sector with EPS growth of 15.4%. Solid profitability with 11.3% net margin and 15.2% operating margin demonstrating operational efficiency.
What are the risks of investing in UFPT?
Claude: Negative free cash flow of -$2.5M despite $17.5M net income indicates poor cash conversion and working capital concerns. Operating cash flow of only $3.2M (2.1% of revenue) is inadequate for sustainable operations and debt servicing.
What is UFPT's revenue and growth?
Ufp Technologies Inc. reported revenue of $154.2M.
Does UFPT pay dividends?
Ufp Technologies Inc. does not currently pay dividends.
Where can I find UFPT SEC filings?
Official SEC filings for Ufp Technologies Inc. (CIK: 0000914156) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is UFPT's EPS?
Ufp Technologies Inc. has a diluted EPS of $2.24.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is UFPT's fundamental grade?
Based on our AI fundamental analysis in June 2026, Ufp Technologies Inc. has a B grade with 62% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is UFPT stock overvalued or undervalued?
Valuation metrics for UFPT: ROE of 4.0% (sector avg: 15%), net margin of 11.3% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is UFPT's AI grade for 2026?
Our dual AI analysis gives Ufp Technologies Inc. a combined B grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is UFPT's free cash flow?
Ufp Technologies Inc.'s operating cash flow is $3.2M, with capital expenditures of $5.7M. FCF margin is -1.6%.
How does UFPT compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin 11.3% (avg: 12%), ROE 4.0% (avg: 15%), current ratio 2.91 (avg: 2).